Multiple cycles of dose-intensive chemotherapy with repeated stem cell support as induction treatment in metastatic breast cancer: a feasibility study.

about

Multiple cycles of dose-intensive chemotherapy with repeated stem cell support as induction treatment in metastatic breast cancer: a feasibility study.

Item

http://www.wikidata.org/entity/Q40597010

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

2001年论文

@zh

2001年论文

@zh-cn

name

Multiple cycles of dose-intens ...... t cancer: a feasibility study.

@en

type

Item

label

Multiple cycles of dose-intens ...... t cancer: a feasibility study.

@en

prefLabel

Multiple cycles of dose-intens ...... t cancer: a feasibility study.

@en

P1476

Multiple cycles of dose-intens ...... t cancer: a feasibility study.

@en

P2093

Azinovic I

http://www.w3.org/2001/XMLSchema#string

Brugarolas A

http://www.w3.org/2001/XMLSchema#string

Fernández-Hidalgo O

http://www.w3.org/2001/XMLSchema#string

García-Rayo S

http://www.w3.org/2001/XMLSchema#string

Martín-Algarra S

http://www.w3.org/2001/XMLSchema#string

Martínez-Aguillo M

http://www.w3.org/2001/XMLSchema#string

Martínez-Monge R

http://www.w3.org/2001/XMLSchema#string

Pérez-Calvo J

http://www.w3.org/2001/XMLSchema#string

Rebollo J

http://www.w3.org/2001/XMLSchema#string

Subirá L

http://www.w3.org/2001/XMLSchema#string

P2860

Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer

Reporting results of cancer treatment

Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multi

Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients.

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group.

Assessment of response to therapy in advanced breast cancer.

The use of drugs in combination for the treatment of cancer: rationale and results.

The importance of dose intensity in chemotherapy of metastatic breast cancer.

Minimal residual disease in solid tumor malignancies: a review.

A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: summation dose-intensity.

P2888

sj.bmt.1703125

P304

235-242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BMT.1703125

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2001-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11810408

http://www.w3.org/2001/XMLSchema#string

P6179

1046513373

http://www.w3.org/2001/XMLSchema#string

P698

11535990

http://www.w3.org/2001/XMLSchema#string